RSV Protection for Italian Babies: Two Ways to Save Money and Health

Babies in Italy can get very sick from a virus called RSV. It hurts their lungs. Scientists wanted to know how to stop this. They looked at two ideas. One idea gives a shot to the baby. The other gives a vaccine to the mother before birth. They compared these ideas to doing nothing at all.

The baby shot is named nirsevimab. Researchers tested it in big studies called MELODY and another one. It protects the baby for about six months. The mother's vaccine comes from a study called MATISSE. It also protects the baby for about six months. After seven months, neither one works. The scientists only looked at one virus season.

The numbers show big differences. With the mother's vaccine, about 68,358 fewer babies need a doctor for lung trouble. It also prevents 6,417 later health problems. This saves about 24.5 million euros for the health system. With the baby shot, about 118,123 fewer babies get sick. It prevents 8,480 later problems. That saves about 34.2 million euros.

Both choices help keep babies safe. But hospitals and clinics must be ready. Doctors need to talk with pregnant women and parents. Families should not miss these chances to protect their babies. Leaders can use this information to make better health rules.